Codexis, Inc. 4QK.F Stock
Codexis, Inc. Price Chart
Codexis, Inc. 4QK.F Financial and Trading Overview
| Codexis, Inc. stock price | 3.26 EUR |
| Previous Close | 2.59 EUR |
| Open | 2.61 EUR |
| Bid | 2.61 EUR x 89300 |
| Ask | 2.64 EUR x 86300 |
| Day's Range | 2.61 - 2.61 EUR |
| 52 Week Range | 2.03 - 12.69 EUR |
| Volume | 691 EUR |
| Avg. Volume | 39 EUR |
| Market Cap | 177.83M EUR |
| Beta (5Y Monthly) | 1.636619 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.87 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 29.5 EUR |
4QK.F Valuation Measures
| Enterprise Value | 108.09M EUR |
| Trailing P/E | N/A |
| Forward P/E | -5.013462 |
| PEG Ratio (5 yr expected) | -4.34 |
| Price/Sales (ttm) | 1.5299774 |
| Price/Book (mrq) | 1.3800954 |
| Enterprise Value/Revenue | 0.93 |
| Enterprise Value/EBITDA | -2.62 |
Trading Information
Codexis, Inc. Stock Price History
| Beta (5Y Monthly) | 1.636619 |
| 52-Week Change | -70.58% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12.69 EUR |
| 52 Week Low | 2.03 EUR |
| 50-Day Moving Average | 3.07 EUR |
| 200-Day Moving Average | 4.83 EUR |
4QK.F Share Statistics
| Avg. Volume (3 month) | 39 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 66.77M |
| Float | 59.99M |
| Short Ratio | N/A |
| % Held by Insiders | 3.00% |
| % Held by Institutions | 94.97% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -41.16% |
| Operating Margin (ttm) | -40.36% |
| Gross Margin | 4.25% |
| EBITDA Margin | -35.48% |
Management Effectiveness
| Return on Assets (ttm) | -12.93% |
| Return on Equity (ttm) | -33.62% |
Income Statement
| Revenue (ttm) | 116.23M EUR |
| Revenue Per Share (ttm) | 1.77 EUR |
| Quarterly Revenue Growth (yoy) | -63.29% |
| Gross Profit (ttm) | 20.46M EUR |
| EBITDA | -41250000 EUR |
| Net Income Avi to Common (ttm) | -47853000 EUR |
| Diluted EPS (ttm) | -0.72 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 102.83M EUR |
| Total Cash Per Share (mrq) | 1.54 EUR |
| Total Debt (mrq) | 42.34M EUR |
| Total Debt/Equity (mrq) | 33.6 EUR |
| Current Ratio (mrq) | 3.392 |
| Book Value Per Share (mrq) | 1.889 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 13.26M EUR |
| Levered Free Cash Flow (ttm) | 20.71M EUR |
Profile of Codexis, Inc.
| Country | Germany |
| State | CA |
| City | Redwood City |
| Address | 200 Penobscot Drive |
| ZIP | 94063 |
| Phone | 650 421 8100 |
| Website | https://www.codexis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 248 |
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Q&A For Codexis, Inc. Stock
What is a current 4QK.F stock price?
Codexis, Inc. 4QK.F stock price today per share is 3.26 EUR.
How to purchase Codexis, Inc. stock?
You can buy 4QK.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Codexis, Inc.?
The stock symbol or ticker of Codexis, Inc. is 4QK.F.
Which industry does the Codexis, Inc. company belong to?
The Codexis, Inc. industry is Biotechnology.
How many shares does Codexis, Inc. have in circulation?
The max supply of Codexis, Inc. shares is 71.85M.
What is Codexis, Inc. Price to Earnings Ratio (PE Ratio)?
Codexis, Inc. PE Ratio is now.
What was Codexis, Inc. earnings per share over the trailing 12 months (TTM)?
Codexis, Inc. EPS is -0.87 EUR over the trailing 12 months.
Which sector does the Codexis, Inc. company belong to?
The Codexis, Inc. sector is Healthcare.